Page 2 - Alkermes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alkermes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alkermes Today - Breaking & Trending Today

Alkermes plc (NASDAQ:ALKS) Given Average Rating of "Moderate Buy" by Analysts

Shares of Alkermes plc (NASDAQ:ALKS – Get Free Report) have earned an average recommendation of “Moderate Buy” from the ten analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and six have issued a buy recommendation on […] ....

Los Angeles , United States , Christian Todd Nichols , Piper Sandler , Raymond James Associates , Principal Financial Group Inc , Advisorshares Investments , Victory Capital Management Inc , Securities Exchange Commission , Los Angeles Capital Management , Jefferies Financial Group , Get Free Report , Financial Group , Todd Nichols , Exchange Commission , Capital Management , Angeles Capital Management , Shares Investments , Get Free , Alkermes Daily ,

Alkermes to Present Data for ALKS 2680 in Narcolepsy Treatment

Alkermes will present new data for its investigational narcolepsy treatment, ALKS 2680, at SLEEP 2024 in Houston. ....

United States , Craig Hopkinson , Michaelj Doane , Ron Grunstein , Davidt Plante , University Of Wisconsin , Woolcock Institute Of Medical Research , Study Data , Wakefulness Test , Karolinska Sleepiness Scale , Woolcock Institute , Associate Professor ,

Alkermes plc to Post Q3 2024 Earnings of $0.63 Per Share, Zacks Research Forecasts (NASDAQ:ALKS)

Alkermes plc (NASDAQ:ALKS – Free Report) – Zacks Research boosted their Q3 2024 earnings per share estimates for Alkermes in a report released on Wednesday, May 22nd. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.63 for the quarter, up from their previous estimate of $0.57. The […] ....

United States , New Zealand General , New Zealand , Robertw Baird , Christian Todd Nichols , Vanguard Group Inc , Hr Department , Alkermes Company Profile , Cantor Fitzgerald , Wellington Management Group , Zacks Research , Norges Bank , Pricet Rowe Associates Inc , Jefferies Financial Group , Free Report , Financial Group , Stock Down , Get Free Report , Todd Nichols , Management Group , Alkermes Daily ,

Artisan Partners Limited Partnership Boosts Stock Holdings in Alkermes plc (NASDAQ:ALKS)

Artisan Partners Limited Partnership grew its position in Alkermes plc (NASDAQ:ALKS – Free Report) by 10.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,066,020 shares of the company’s stock after buying an additional 188,289 shares during the period. Artisan Partners Limited Partnership owned 1.24% […] ....

United States , Christian Todd Nichols , Robertw Baird , Cm Bidwell Associates Ltd , Headlands Technologies , Mcglone Suttner Wealth Management Inc , Daiwa Securities Group Inc , Cantor Fitzgerald , Artisan Partners Limited Partnership , Free Report , Partners Limited Partnership , Glone Suttner Wealth Management , Securities Group , Get Free Report , Todd Nichols , Alkermes Daily ,

J&J antidepressant eases symptoms, improves sleep in key trial

BioPharma ....

United States , Bristol Myers Squibb , Jazz Pharmaceuticals , Dive Brief ,